BioSpace News Archive

Royal Philips, a global leader in health technology, showcases the world’s first mobile MRI system with helium-free operations at #RSNA23.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the publication of two abstracts regarding MCLA-129 on the European Society for Medical Oncology Asia Congress website.

Mesoblast Limited announced that it has filed for orphan drug designation and rare pediatric disease designation with the United States Food and Drug Administration for its allogeneic cell therapy Revascor® in the treatment of the congenital heart disease hypoplastic left heart syndrome.

GE HealthCare will highlight more than 40 innovations, including several key artificial intelligence -enabled technologies within the Imaging, Ultrasound, and digital space at the Radiological Society of North America’s 2023 Annual Meeting taking place Nov. 26-30 in Chicago, IL.

Median Technologies unveils a new identity, including a new name, logo, tagline for its iBiopsy® AI/ML tech-based suite of software as medical devices and business unit, as part of an extensive rebranding initiative.

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, has published positive results from a human clinical trial involving its potentially game-changing technology that enables vaccines to be applied to the skin using a small patch, instead of using traditional needle and syringe.

Konica Minolta Healthcare Americas, Inc., announced several new solutions in digital radiography and ultrasound that will be introduced at the 2023 Radiology Society of North America Scientific Assembly and Annual Meeting from November 26-30 in Chicago, IL.

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, will be presenting at the Clinical Research Governance World Conference & International Clinical Trial Center Network Symposium 2023 in Hong Kong this month.

EnGeneIC, a pioneer in personalised cancer therapeutics, announces the publication of its clinical trial results in peer reviewed prestigious journal “Clinical Cancer Research”, published by the American Association for Cancer Research.